U.S. markets closed
  • S&P Futures

    3,830.50
    -8.50 (-0.22%)
     
  • Dow Futures

    31,483.00
    +18.00 (+0.06%)
     
  • Nasdaq Futures

    12,551.75
    -112.00 (-0.88%)
     
  • Russell 2000 Futures

    2,192.00
    +2.30 (+0.11%)
     
  • Crude Oil

    67.52
    +1.43 (+2.16%)
     
  • Gold

    1,703.70
    +5.20 (+0.31%)
     
  • Silver

    25.68
    +0.40 (+1.57%)
     
  • EUR/USD

    1.1906
    -0.0018 (-0.15%)
     
  • 10-Yr Bond

    1.5540
    +0.0040 (+0.26%)
     
  • Vix

    24.66
    -3.91 (-13.69%)
     
  • GBP/USD

    1.3819
    -0.0009 (-0.07%)
     
  • USD/JPY

    108.3850
    +0.0030 (+0.00%)
     
  • BTC-USD

    50,423.09
    +687.53 (+1.38%)
     
  • CMC Crypto 200

    1,020.41
    +77.24 (+8.19%)
     
  • FTSE 100

    6,630.52
    -20.36 (-0.31%)
     
  • Nikkei 225

    28,780.09
    -84.23 (-0.29%)
     

AxoGen: 4Q Earnings Snapshot

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

ALACHUA, Fla. (AP) _ AxoGen Inc. (AXGN) on Monday reported a loss of $6 million in its fourth quarter.

The Alachua, Florida-based company said it had a loss of 15 cents per share. Losses, adjusted for stock option expense, were 8 cents per share.

The regenerative medicine company posted revenue of $32.5 million in the period.

For the year, the company reported that its loss narrowed to $23.8 million, or 60 cents per share. Revenue was reported as $112.3 million.

AxoGen shares have climbed 19% since the beginning of the year. In the final minutes of trading on Monday, shares hit $21.32, a rise of 43% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AXGN at https://www.zacks.com/ap/AXGN